Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioNTech
Biotech
FDA allows BioNTech-MediLink ADC trial to resume at lower doses
BioNTech confirmed that it would focus solely on doses no higher than 3 mg/kg.
James Waldron
Aug 19, 2024 8:45am
Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B
Aug 16, 2024 8:25am
BioNTech ends work on Genmab-partnered bispecific antibody
Aug 5, 2024 7:50am
BioNTech, Regeneron rack up response rate win for cancer vaccine
Jul 30, 2024 6:45am
FDA halts BioNTech ADC trial over 'significant risk of illness'
Jun 17, 2024 9:17am
BioNTech pays $25M to strengthen ADC bond with China's MediLink
May 28, 2024 7:25am